#IncretinSignaling | #Metabolic | #ReceptorBiology

GLP2-T— Research Overview (RUO)

GLP2-T is a synthetic peptide research ligand utilized in laboratory and in-vitro research settings to examine signaling interactions involving incretin-related receptors. It is investigated as a dual-receptor signaling model to support mechanistic research into metabolic pathway integration under controlled experimental conditions.

This material is supplied strictly as a chemical reference standard for laboratory research use only and is not intended for diagnostic, therapeutic, or clinical applications.

Compound Name:

GLP2-T

Mechanistic Classification

Dual Incretin Receptor Research Ligand

Structure

Modified linear peptide with lipid-associated moiety for experimental signaling studies

Primary Research Focus

Incretin receptor signaling interaction models

Chemical Formula

C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight

~4813.5 g/mol

Sequence Length

39 Amino Acids

Structure Note

Derived from incretin-related peptide frameworks and modified to support experimental investigation of receptor signaling behavior in controlled laboratory systems. Structural modifications are intended to enhance experimental stability and receptor interaction modeling and do not imply biological or therapeutic function.

Store lyophilized material under conditions appropriate for laboratory reference compounds. Protect from moisture and light.

For laboratory research use only. Reconstitute using sterile bacteriostatic water consistent with established laboratory research protocols. Preparation should be performed under aseptic conditions. Reconstituted material is not intended for long-term storage.

Sequence Length

Mechanistic & Experimental Research Sections

Dual Incretin Receptor Signaling Models

GLP2-T is used in experimental research frameworks to explore simultaneous receptor signaling dynamics within incretin-associated pathways. Research focuses on receptor interaction patterns, intracellular signaling cascades, and pathway integration under controlled conditions.

Receptor signaling interaction mapping
Comparative pathway activation studies
Downstream intracellular signaling assessment

Metabolic Pathway Research Models

Experimental systems utilize GLP2-T to examine how combined receptor signaling influences metabolic pathway markers in non-clinical research environments.

Signal transduction pathway modulation
Cellular energy-related signaling markers
Receptor-dependent transcriptional responses

Glucose Signaling Research Context

Laboratory studies evaluate receptor-mediated signaling events associated with glucose-related pathways using in-vitro and preclinical experimental models.

Receptor-linked intracellular signaling
Beta-cell signaling mechanisms (experimental models only)
Pathway-specific response profiling

Lipid & Adipocyte Signaling Research

In experimental systems, incretin-related signaling pathways are examined for their influence on adipocyte-associated cellular processes.

Lipid signaling pathway modulation
Cellular storage and mobilization signaling markers
Tissue-specific receptor signaling behavior

Research Limitations

Model Dependence: Observed signaling effects are dependent on experimental design and model system selection.
Species Variability: Receptor expression and signaling responses may differ across experimental models and are not directly translatable.
Non-Clinical Scope: Findings are limited to laboratory research contexts and do not imply therapeutic relevance.

Selected Scientific Literature (Background Context)

The following publications are provided solely as background literature related to incretin receptor research and do not represent studies of this specific material:

Finan, B., et al. (2013). Science Translational Medicine
Coskun, T., et al. (2018). Molecular Metabolism
Frias, J. P., et al. (2018). The Lancet

The compound listed below is referenced in research contexts related to the mechanisms discussed in this article.

GLP2-T is a chemical reference standard intended strictly for laboratory and in-vitro research applications. It is not a drug, dietary supplement, or medical product and is not intended for human or animal consumption, administration, diagnosis, or therapeutic use. All handling must be conducted by qualified personnel in appropriate research environments.

GLP2-T— Research Overview (RUO)

Compound Name:

Mechanistic Classification

Structure

Primary Research Focus

Chemical Formula

Molecular Weight

Sequence Length

Structure Note

Sequence Length

Dual Incretin Receptor Signaling Models

Age Verification Required

NAD+ Buffered

MOTS-c

KPV

KLOW Blend

Ipamorelin

HGH Fragment 176-191

Glutathione

GLOW Blend

GHK-Cu